Publication & Research
Comparing glaucomatous disc change using stereo disc viewing and the MatchedFlicker programme in glaucoma experts and trainees.
Schaefer JL, Meyer AM, Rodgers CD, Rosenberg NC, Leoncavallo AJ, Lukowski ZL, Greer AB, Martorana GM, Zou B, Shuster JJ, Jay Katz L, Schuman JS, Kass MA, Sherwood MB
Br J Ophthalmol. 2017 Aug 16; pii: bjophthalmol-2017-310336. doi: 10.1136/bjophthalmol-2017-310336.
PMID:
28814418
[PubMed - as supplied by publisher]
Related citations
Anti-VEGF Injections and Glaucoma Surgery.
Apte RS, Gordon M, Kass MA
JAMA Ophthalmol. 2017 Apr 1; 135(4)368-369. doi: 10.1001/jamaophthalmol.2017.0148.
PMID:
28301640
[PubMed - in process]
Related citations
Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study.
Scheetz TE, Faga B, Ortega L, Roos BR, Gordon MO, Kass MA, Wang K, Fingert JH
Ophthalmology. 2016 Dec; 123(12)2527-2536. doi: 10.1016/j.ophtha.2016.08.036.
PMID:
27707548
[PubMed - indexed for MEDLINE]
Related citations
A Common Variant in MIR182 Is Associated With Primary Open-Angle Glaucoma in the NEIGHBORHOOD Consortium.
Liu Y, Bailey JC, Helwa I, Dismuke WM, Cai J, Drewry M, Brilliant MH, Budenz DL, Christen WG, Chasman DI, Fingert JH, Gaasterland D, Gaasterland T, Gordon MO, Igo RP Jr, Kang JH, Kass MA, Kraft P, Lee RK, Lichter P, Moroi SE, Realini A, Richards JE, Ritch R, Schuman JS, Scott WK, Singh K, Sit AJ, Song YE, Vollrath D, Weinreb R, Medeiros F, Wollstein G, Zack DJ, Zhang K, Pericak-Vance MA, Gonzalez P, Stamer WD, Kuchtey J, Kuchtey RW, Allingham RR, Hauser MA, Pasquale LR, Haines JL, Wiggs JL
Invest Ophthalmol Vis Sci. 2016 Aug 1; 57(10)3974-81. doi: 10.1167/iovs.16-19688.
PMID:
27537254
[PubMed - indexed for MEDLINE]
Related citations
Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension.
Christopher M, Abràmoff MD, Tang L, Gordon MO, Kass MA, Budenz DL, Fingert JH, Scheetz TE
Invest Ophthalmol Vis Sci. 2015 Jul; 56(8)4470-9. doi: 10.1167/iovs.14-16142.
PMID:
26193923
[PubMed - indexed for MEDLINE]
Related citations
Photoacoustic tomography imaging and estimation of oxygen saturation of hemoglobin in ocular tissue of rabbits.
Hennen SN, Xing W, Shui YB, Zhou Y, Kalishman J, Andrews-Kaminsky LB, Kass MA, Beebe DC, Maslov KI, Wang LV
Exp Eye Res. 2015 Sep; 138153-8. doi: 10.1016/j.exer.2015.05.022.
PMID:
26048477
[PubMed - indexed for MEDLINE]
Related citations
Longitudinal changes in peripapillary atrophy in the ocular hypertension treatment study: a case-control assessment.
Savatovsky E, Mwanza JC, Budenz DL, Feuer WJ, Vandenbroucke R, Schiffman JC, Anderson DR, Ocular Hypertension Treatment Study.
Ophthalmology. 2015 Jan; 122(1)79-86. doi: 10.1016/j.ophtha.2014.07.033.
PMID:
25208858
[PubMed - indexed for MEDLINE]
Related citations
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study.
Zangwill LM, Jain S, Dirkes K, He F, Medeiros FA, Trick GL, Brandt JD, Cioffi GA, Coleman AL, Liebmann JM, Piltz-Seymour JR, Gordon MO, Kass MA, Weinreb RN, Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
Am J Ophthalmol. 2013 Jun; 155(6)971-82. doi: 10.1016/j.ajo.2013.01.020.
PMID:
23497845
[PubMed - indexed for MEDLINE]
Related citations
Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study.
Gardiner SK, Demirel S, Gordon MO, Kass MA, Ocular Hypertension Treatment Study Group.
Ophthalmology. 2013 Apr; 120(4)724-30. doi: 10.1016/j.ophtha.2012.09.056.
PMID:
23357622
[PubMed - indexed for MEDLINE]
Related citations
Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study.
Gardiner SK, Demirel S, De Moraes CG, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, Ocular Hypertension Treatment Study Group.
Invest Ophthalmol Vis Sci. 2013 Feb 15; 54(2)1252-9. doi: 10.1167/iovs.12-10218.
PMID:
23349433
[PubMed - indexed for MEDLINE]
Related citations
Rate of visual field progression in eyes with optic disc hemorrhages in the ocular hypertension treatment study.
De Moraes CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA
Arch Ophthalmol. 2012 Dec; 130(12)1541-6. doi: 10.1001/jamaophthalmol.2013.1137.
PMID:
23229692
[PubMed - indexed for MEDLINE]
Related citations
The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysis.
Gao F, Miller JP, Miglior S, Beiser JA, Torri V, Kass MA, Gordon MO
BMC Med Res Methodol. 2012 Oct 4; 12151. doi: 10.1186/1471-2288-12-151.
PMID:
23035867
[PubMed - indexed for MEDLINE]
Related citations
Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study.
Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD, Wilson B, Kass MA, Ocular Hypertension Treatment Study Group.
Ophthalmology. 2012 Sep; 119(9)1826-31. doi: 10.1016/j.ophtha.2012.02.050.
PMID:
22608478
[PubMed - indexed for MEDLINE]
Related citations
Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.
De Moraes CG, Demirel S, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, Ocular Hypertension Treatment Study Group.
Invest Ophthalmol Vis Sci. 2012 Apr 2; 53(4)1704-9. doi: 10.1167/iovs.11-8186.
PMID:
22395889
[PubMed - indexed for MEDLINE]
Related citations
A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG).
Gao F, Miller JP, Miglior S, Beiser JA, Torri V, Kass MA, Gordon MO
JP J Biostat. 2011 May 1; 5(2)73-96.
PMID:
22180704
[PubMed]
Related citations
The 10-year incidence of glaucoma among patients with treated and untreated ocular hypertension.
Gordon MO, Gao F, Beiser JA, Miller JP, Kass MA
Arch Ophthalmol. 2011 Dec; 129(12)1630-1. doi: 10.1001/archophthalmol.2011.337.
PMID:
22159688
[PubMed - indexed for MEDLINE]
Related citations
The rate of visual field change in the ocular hypertension treatment study.
Demirel S, De Moraes CG, Gardiner SK, Liebmann JM, Cioffi GA, Ritch R, Gordon MO, Kass MA, Ocular Hypertension Treatment Study Group.
Invest Ophthalmol Vis Sci. 2012 Jan 25; 53(1)224-7. doi: 10.1167/iovs.10-7117.
PMID:
22159015
[PubMed - indexed for MEDLINE]
Related citations
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.
Brandt JD, Gordon MO, Gao F, Beiser JA, Miller JP, Kass MA, Ocular Hypertension Treatment Study Group.
Ophthalmology. 2012 Mar; 119(3)437-42. doi: 10.1016/j.ophtha.2011.03.018.
PMID:
21705084
[PubMed - indexed for MEDLINE]
Related citations
Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.
Artes PH, Chauhan BC, Keltner JL, Cello KE, Johnson CA, Anderson DR, Gordon MO, Kass MA, Ocular Hypertension Treatment Study Group.
Arch Ophthalmol. 2010 Dec; 128(12)1528-32. doi: 10.1001/archophthalmol.2010.292.
PMID:
21149774
[PubMed - indexed for MEDLINE]
Related citations
Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.
Weinreb RN, Zangwill LM, Jain S, Becerra LM, Dirkes K, Piltz-Seymour JR, Cioffi GA, Trick GL, Coleman AL, Brandt JD, Liebmann JM, Gordon MO, Kass MA, OHTS CSLO Ancillary Study Group.
Ophthalmology. 2010 Sep; 117(9)1674-83. doi: 10.1016/j.ophtha.2010.03.044.
PMID:
20633931
[PubMed - indexed for MEDLINE]
Related citations